We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

2 hedge funds and large institutions have $69K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 151 → 2 (-149)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 148

100% less funds holding in top 10

Funds holding in top 10: 14 → 0 (-14)

100% less capital invested

Capital invested by funds: $2.42B → $69K (-$2.42B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-149
Holders Change %
-98.68%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
148
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCS
Crosspoint Capital Strategies
California
+$2.83K

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$273M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$229M
3
O
OppenheimerFunds
New York
-$171M
4
Fidelity International
Fidelity International
Bermuda
-$148M
5
MICM
Matthews International Capital Management
California
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACI
51
AMP Capital Investors
Australia
– -$6.92M -159,992 Closed
Barclays
52
Barclays
United Kingdom
– -$6.43M -149,583 Closed
WCM Investment Management
53
WCM Investment Management
California
– -$6.42M -148,489 Closed
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
– -$6.1M -141,240 Closed
LMGAM
55
Liberty Mutual Group Asset Management
Massachusetts
– -$6.01M -139,122 Closed
Citigroup
56
Citigroup
New York
– -$5.82M -134,779 Closed
NONA
57
Ninety One North America
New York
– -$5.27M -122,006 Closed
GF
58
Gabelli Funds
New York
– -$5.1M -118,000 Closed
Marshall Wace
59
Marshall Wace
United Kingdom
– -$4.56M -105,619 Closed
Northern Trust
60
Northern Trust
Illinois
– -$4.47M -103,404 Closed
Lazard Asset Management
61
Lazard Asset Management
New York
– -$4.39M -101,561 Closed
PG
62
PEAK6 Group
Illinois
– -$4.14M -95,900 Closed
TI
63
TT International
United Kingdom
– -$3.78M -87,566 Closed
GCIA
64
Gabelli & Co Investment Advisers
New York
– -$3.6M -83,267 Closed
RSS
65
Rosenblum Silverman Sutton
California
– -$3.57M -82,610 Closed
State Street
66
State Street
Massachusetts
– -$3.53M -81,773 Closed
Boston Partners
67
Boston Partners
Massachusetts
– -$3.46M -80,000 Closed
Goldman Sachs
68
Goldman Sachs
New York
– -$3.2M -73,980 Closed
CAIMH
69
Central Asset Investments & Management Holdings
Hong Kong
– -$2.97M -68,815 Closed
WAM
70
Wolverine Asset Management
Illinois
– -$2.94M -68,155 Closed
IAM
71
Integre Asset Management
New York
– -$2.88M -66,746 Closed
CCM
72
Causeway Capital Management
California
– -$2.83M -65,400 Closed
GH
73
GAM Holding
Switzerland
– -$2.78M -64,400 Closed
Zurich Cantonal Bank
74
Zurich Cantonal Bank
Switzerland
– -$2.69M -62,143 Closed
GI
75
GAMCO Investors
Connecticut
– -$2.65M -61,300 Closed
1 2
3
4 5

WX Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2015, worth a combined $69K — down 100% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 148 funds closed out of WX and 1 opened new positions — a net loss of 147 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $2.83K. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $273M sold.

  • 2 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2015, down from 151 in Q3 2015.
  • Funds reported $69K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2015, down 100% quarter-over-quarter.
  • 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2015 and 148 closed out, a net change of -147 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $2.83K added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2015 was Schroder Investment Management Group, an estimated $273M sold.

Based on aggregated 13F filings for Q4 2015.